[Should I treat a high-risk chronic coronary syndrome in an invasive way from the beginning? No, in most cases].
José María Carrasco RuedaRené Ricardo Rodríguez OlivaresLuis Murillo PérezJuan-Manuel Muñoz-MorenoAlayo Lizana Carlos AlbertoPublished in: Archivos peruanos de cardiologia y cirugia cardiovascular (2020)
The definition of the high-risk chronic coronary syndrome varies depending on the noninvasive test used to trigger ischemia. The triggering occurs through increased myocardial work and oxygen demand, either through exercise or drugs. The initial approach to the chronic coronary syndrome leads us to discuss in which cases to prioritize an optimal initial medical therapy or to perform an initial invasive procedure of myocardial revascularization. In this article, we analyze both approaches based on previous studies carried out to date, where the initial invasive management has not been shown to be superior to initial optimal medical therapy in outcomes such as death or major adverse cardiovascular events.
Keyphrases
- coronary artery disease
- cardiovascular events
- coronary artery
- healthcare
- case report
- left ventricular
- coronary artery bypass grafting
- stem cells
- physical activity
- aortic stenosis
- type diabetes
- atrial fibrillation
- mesenchymal stem cells
- skeletal muscle
- transcatheter aortic valve replacement
- metabolic syndrome
- replacement therapy